The technology of creating heart valves using the child's own umbilical cord cells

References

[1] Dvorin E.L., Wylie-Sears J., Kaushal S. et al. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta-1. Tissue Eng. 2003; 9[3): 487-93.

[2] Gunal N., Baysal K., Haciomeroglu P. et al. Rheumatic heart disease and coronary vasculitis in children. Acta Paediatr. 2006; 95(1 ): 118-20.

[3] Knight R.L., Booth C., Wilcox H.E. et al. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J. Heart Valve Dis. 2005; 14(6): 806-13.

[4] Sawaki S., Usui A., Abe T. et al. Late mortality and morbidity in elderly patients with mechanical heart valves. Asian Cardiovasc. Thorac. Ann. 2006; 14(3): 189-94.

[5] Sutherland F.W., Perry T.E., Yu Y. et al. From stem cells to viable autologous semilunar heart valve. Circulation 2005; 111(21): 2783-91.

[6] Takagi K., Fukunaga S., Nishi A. et al. In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study. Artif. Organs 2006; 30(4): 233-41.

[7] Tiete A.R., Sachweh J.S., Groetzner J. et al. Systemic mechanical heart valve replacement in children under 16 years of age. Clin. Res. Cardiol. 2006; 95(5): 281-8.

[8] Visconti R., Mironov V., Kasyanov V.A. et al. Cardiovascular tissue engineering I. Perfusion bioreactors: a review. J. Long Term. Eff. Med. Implants. 2006; 16(2): 111-30.

RIGHTS & PERMISSIONS

Eco-Vector